Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development

  1. Keisuke Nimura  Is a corresponding author
  2. Masamichi Yamamoto
  3. Makiko Takeichi
  4. Kotaro Saga
  5. Katsuyoshi Takaoka
  6. Norihiko Kawamura
  7. Hirohisa Nitta
  8. Hiromichi Nagano
  9. Saki Ishino
  10. Tatsuya Tanaka
  11. Robert J Schwartz
  12. Hiroyuki Aburatani
  13. Yasufumi Kaneda
  1. Osaka University Graduate School of Medicine, Japan
  2. Kyoto University Graduate School of Medicine, Japan
  3. Osaka University, Japan
  4. University of Houston, United States
  5. The University of Tokyo, Japan

Abstract

Transcription factors organize gene expression profiles by regulating promoter activity. However, the role of transcription factors after transcription initiation is poorly understood. Here, we show that the homeoprotein Nkx2-5 and the 5'-3' exonuclease Xrn2 are involved in the regulation of alternative polyadenylation (APA) during mouse heart development. Nkx2-5 occupied not only the transcription start sites (TSSs) but also the downstream regions of genes, serving to connect these regions in primary embryonic cardiomyocytes (eCMs). Nkx2-5 deficiency affected Xrn2 binding to target loci and resulted in increases in RNA polymerase II (RNAPII) occupancy and in the expression of mRNAs with long 3'untranslated regions (3' UTRs) from genes related to heart development. siRNA-mediated suppression of Nkx2-5 and Xrn2 led to heart looping anomaly. Moreover, Nkx2-5 genetically interacts with Xrn2 because Nkx2-5+/-Xrn2+/-, but neither Nkx2-5+/- nor Xrn2+/-, newborns exhibited a defect in ventricular septum formation, suggesting that the association between Nkx2-5 and Xrn2 is essential for heart development. Our results indicate that Nkx2-5 regulates not only the initiation but also the usage of poly(A) sites during heart development. Our findings suggest that tissue-specific transcription factors is involved in the regulation of APA.

Article and author information

Author details

  1. Keisuke Nimura

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    For correspondence
    nimura@gts.med.osaka-u.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
  2. Masamichi Yamamoto

    Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. Makiko Takeichi

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  4. Kotaro Saga

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Katsuyoshi Takaoka

    Developmental Genetics Group, Osaka University, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Norihiko Kawamura

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Hirohisa Nitta

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Hiromichi Nagano

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  9. Saki Ishino

    Center for Medical Research and Education, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  10. Tatsuya Tanaka

    Center for Medical Research and Education, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.
  11. Robert J Schwartz

    Department of Biology and Biochemistry, University of Houston, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Hiroyuki Aburatani

    Genome Science Division, The University of Tokyo, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
  13. Yasufumi Kaneda

    Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: The protocols (3422-1 and 24-084-012) are approved by the Ethics Committee for Animal Experiments of the Osaka University Graduate School of Medicine.with protocols

Copyright

© 2016, Nimura et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,245
    views
  • 570
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Keisuke Nimura
  2. Masamichi Yamamoto
  3. Makiko Takeichi
  4. Kotaro Saga
  5. Katsuyoshi Takaoka
  6. Norihiko Kawamura
  7. Hirohisa Nitta
  8. Hiromichi Nagano
  9. Saki Ishino
  10. Tatsuya Tanaka
  11. Robert J Schwartz
  12. Hiroyuki Aburatani
  13. Yasufumi Kaneda
(2016)
Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development
eLife 5:e16030.
https://doi.org/10.7554/eLife.16030

Share this article

https://doi.org/10.7554/eLife.16030

Further reading

    1. Chromosomes and Gene Expression
    2. Developmental Biology
    Roger Huerlimann, Natacha Roux ... Timothy Ravasi
    Research Article

    Most teleost fishes exhibit a biphasic life history with a larval oceanic phase that is transformed into morphologically and physiologically different demersal, benthic, or pelagic juveniles. This process of transformation is characterized by a myriad of hormone-induced changes, during the often abrupt transition between larval and juvenile phases called metamorphosis. Thyroid hormones (TH) are known to be instrumental in triggering and coordinating this transformation but other hormonal systems such as corticoids, might be also involved as it is the case in amphibians. In order to investigate the potential involvement of these two hormonal pathways in marine fish post-embryonic development, we used the Malabar grouper (Epinephelus malabaricus) as a model system. We assembled a chromosome-scale genome sequence and conducted a transcriptomic analysis of nine larval developmental stages. We studied the expression patterns of genes involved in TH and corticoid pathways, as well as four biological processes known to be regulated by TH in other teleost species: ossification, pigmentation, visual perception, and metabolism. Surprisingly, we observed an activation of many of the same pathways involved in metamorphosis also at an early stage of the larval development, suggesting an additional implication of these pathways in the formation of early larval features. Overall, our data brings new evidence to the controversial interplay between corticoids and thyroid hormones during metamorphosis as well as, surprisingly, during the early larval development. Further experiments will be needed to investigate the precise role of both pathways during these two distinct periods and whether an early activation of both corticoid and TH pathways occurs in other teleost species.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Erik Toraason, Alina Salagean ... Diana E Libuda
    Research Article

    The preservation of genome integrity during sperm and egg development is vital for reproductive success. During meiosis, the tumor suppressor BRCA1/BRC-1 and structural maintenance of chromosomes 5/6 (SMC-5/6) complex genetically interact to promote high fidelity DNA double strand break (DSB) repair, but the specific DSB repair outcomes these proteins regulate remain unknown. Using genetic and cytological methods to monitor resolution of DSBs with different repair partners in Caenorhabditis elegans, we demonstrate that both BRC-1 and SMC-5 repress intersister crossover recombination events. Sequencing analysis of conversion tracts from homolog-independent DSB repair events further indicates that BRC-1 regulates intersister/intrachromatid noncrossover conversion tract length. Moreover, we find that BRC-1 specifically inhibits error prone repair of DSBs induced at mid-pachytene. Finally, we reveal functional interactions of BRC-1 and SMC-5/6 in regulating repair pathway engagement: BRC-1 is required for localization of recombinase proteins to DSBs in smc-5 mutants and enhances DSB repair defects in smc-5 mutants by repressing theta-mediated end joining (TMEJ). These results are consistent with a model in which some functions of BRC-1 act upstream of SMC-5/6 to promote recombination and inhibit error-prone DSB repair, while SMC-5/6 acts downstream of BRC-1 to regulate the formation or resolution of recombination intermediates. Taken together, our study illuminates the coordinate interplay of BRC-1 and SMC-5/6 to regulate DSB repair outcomes in the germline.